1. Basics in molecular evolution -- 2. Basics in bioinformatics and statistics -- 3. Functional divergence after gene duplication: statistical modeling -- 4. Functional divergence after gene ...

Using the full potential of microarray data as an experimental tool will require appropriate statistical analyses. By its nature, it is quantitative data: data which exhibit continuous, rather than ...

The computer scientist Barbara Engelhardt develops machine-learning models and methods to scour human genomes for the elusive causes and mechanisms of disease. “We don’t have much ground truth in ...

-- New division focused on supporting translation of complex genomic data for drug discovery, drug repositioning, and companion diagnostics development -- SEATTLE, Sept. 24, 2014 /PRNewswire/ -- Axio ...

A deep learning framework combines convolutional and bidirectional recurrent networks to improve protein function prediction from genomic sequences. By automating feature extraction and capturing long ...

SOUTH PLAINFIELD & PRINCETON, N.J. & REHOVOT, Israel--(BUSINESS WIRE)--Rosetta Genomics Ltd. (NASDAQ:ROSG), a leading developer and provider of microRNA-based molecular diagnostics and therapeutics, ...

2bPrecise, a wholly owned subsidiary of Allscripts Healthcare, has launched an early adopter program at the National Institutes of Health. The NIH, a longtime Allscripts Sunrise EHR client, will ...

A systematic review found that genomic classifier tests can influence risk assessments and treatment decisions among patients with localized prostate cancer but studies evaluating these tests vary ...

ST. PETERSBURG, Fla.--(BUSINESS WIRE)--InformedDNA ®, the nation’s leading applied genomics solutions company, today announced it will launch a new evidence-based genomics guidance solution. The new ...

A Chinese gene company selling prenatal tests around the world developed them in collaboration with the country's military and is using them to collect genetic data from millions of women for sweeping ...

A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early prostate cancer are at high risk for their disease to come back quickly after ...